maxacalcitol

Known as: 22-oxacalcitriol, 1,25-dihydroxy-22-oxavitamin D3, maxacalcitriol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Vitamin D compounds have been used successfully to treat secondary hyperparathyroidism for almost three decades. Side effects of… (More)
Is this relevant?
2006
2006
1 alpha,25-dihydroxyvitamin D3 [Calcitriol or 1,25(OH)(2)D(3)] is an important active metabolite involved in multiple functions… (More)
Is this relevant?
2005
2005
The phosphatemic property of maxacalcitol, a newly developed artificial active vitamin D analog, has not been compared with that… (More)
Is this relevant?
2004
2004
The most important etiological factors of resistance to medical treatments for secondary hyperparathyroidism are the decreased… (More)
Is this relevant?
2003
2003
Percutaneous ethanol injection therapy (PEIT) of the parathyroid was originally introduced as an alternative to surgical… (More)
  • figure 1
Is this relevant?
2003
2003
BACKGROUND Although vitamin D has been reported to be useful in the treatment of patients with secondary hyperparathyroidism, it… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Maxacalcitol (22-oxacalcitriol [OCT]) is a newly developed vitamin D analogue in Japan. OCT has shown less calcemic action and a… (More)
Is this relevant?
1997
1997
Decreased nerve growth factor (NGF) synthesis in the hippocampus and reduced nerve growth factor receptor immunoreactivity in CH1… (More)
Is this relevant?
1996
1996
Parathyroid hormone-related protein (PTHrP) is the main cause of humoral hypercalcaemia of malignancy (HHM). We recently… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Data from epidemiological studies has suggested that vitamin D deficiency may promote prostate cancer, although the mechanism is… (More)
Is this relevant?